NEUROSENSE THERAPEUTICS LTD (NRSN) Stock Price, Quote, News and Overview
NASDAQ:NRSN - Nasdaq - IL0011809592 - Common Stock - Currency: USD
NRSN Quote, Performance and Key Statistics
1.89
-0.01 (-0.53%)
The current stock price of NRSN is 1.89 USD. In the past month the price increased by 22.73%. In the past year, price increased by 53.66%.
NRSN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.07 | 327.88B | ||
| AMGN | AMGEN INC | 13.45 | 150.13B | ||
| GILD | GILEAD SCIENCES INC | 14.32 | 137.91B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 114.33B | ||
| REGN | REGENERON PHARMACEUTICALS | 11.85 | 56.68B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 42.52B | ||
| ARGX | ARGENX SE - ADR | 95.86 | 33.66B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.18 | 26.19B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.59B | ||
| NTRA | NATERA INC | N/A | 23.07B | ||
| BIIB | BIOGEN INC | 7.94 | 18.40B | ||
| INSM | INSMED INC | N/A | 18.33B |
Related stock screener links
About NRSN
Company Profile
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company. The firm is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The firm's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Company Info
NEUROSENSE THERAPEUTICS LTD
11 Hamenofim St., Building B
Herzliya IL
Employees: 18
Phone: 97299531142
NEUROSENSE THERAPEUTICS LTD / NRSN FAQ
What is the stock price of NEUROSENSE THERAPEUTICS LTD today?
The current stock price of NRSN is 1.89 USD. The price decreased by -0.53% in the last trading session.
What is the ticker symbol for NEUROSENSE THERAPEUTICS LTD stock?
The exchange symbol of NEUROSENSE THERAPEUTICS LTD is NRSN and it is listed on the Nasdaq exchange.
On which exchange is NRSN stock listed?
NRSN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for NEUROSENSE THERAPEUTICS LTD stock?
9 analysts have analysed NRSN and the average price target is 10.97 USD. This implies a price increase of 480.16% is expected in the next year compared to the current price of 1.89. Check the NEUROSENSE THERAPEUTICS LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NEUROSENSE THERAPEUTICS LTD worth?
NEUROSENSE THERAPEUTICS LTD (NRSN) has a market capitalization of 45.34M USD. This makes NRSN a Nano Cap stock.
How many employees does NEUROSENSE THERAPEUTICS LTD have?
NEUROSENSE THERAPEUTICS LTD (NRSN) currently has 18 employees.
Should I buy NEUROSENSE THERAPEUTICS LTD (NRSN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NRSN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NRSN, evaluating the profitability, health, valuation and growth aspects
- NEUROSENSE THERAPEUTICS LTD (NRSN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NEUROSENSE THERAPEUTICS LTD (NRSN) Sales and EPS estimates to see what analysts future expectations are.
- NEUROSENSE THERAPEUTICS LTD (NRSN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NEUROSENSE THERAPEUTICS LTD (NRSN) Insider and Institutional Ownership to learn about the owners and their transactions.
- NEUROSENSE THERAPEUTICS LTD (NRSN) Stock Chart to make your own analysis
- NEUROSENSE THERAPEUTICS LTD (NRSN) Latest news and press-releases to stay up to date.
Does NEUROSENSE THERAPEUTICS LTD (NRSN) stock pay dividends?
NRSN does not pay a dividend.
What is the Price/Earnings (PE) ratio of NEUROSENSE THERAPEUTICS LTD (NRSN)?
NEUROSENSE THERAPEUTICS LTD (NRSN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.54).
What is the Short Interest ratio of NEUROSENSE THERAPEUTICS LTD (NRSN) stock?
The outstanding short interest for NEUROSENSE THERAPEUTICS LTD (NRSN) is 2.38% of its float. Check the ownership tab for more information on the NRSN short interest.
NRSN Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to NRSN. When comparing the yearly performance of all stocks, NRSN is one of the better performing stocks in the market, outperforming 95.1% of all stocks.
NRSN Financial Highlights
Over the last trailing twelve months NRSN reported a non-GAAP Earnings per Share(EPS) of -0.54. The EPS decreased by -48.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1061.28% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
NRSN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to NRSN. The Buy consensus is the average rating of analysts ratings from 9 analysts.